1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61A22F92C11E8C91600258BE900029CD0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(clinical+and+trial)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10&AQ=clinical+trial
18
19OpenForm&Query=(clinical+and+trial)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10&AQ=clinical+trial
2018.97.9.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 368 Total Hits, Sorted by Relevance.

    |    

Best Practices for Managing Clinical Trials During and Beyond the COVID-19 PandemicDirect access to this research is not included with your membership level.

The COVID-19 pandemic has altered clinical trials timelines and protocols for many pharmaceutical companies, but technological advancements have enab... (ID CM-9)
Companies Profiled: Alcon, Alnylam Pharmaceuticals, Aptus Clinical, Atara Biotherapeutics, more ...

Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies To Ensure Medical Device Success in a Global MarketplaceDirect access to this research is not included with your membership level.

In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities... (ID POP-238)
Companies Profiled: Abbott Vascular, Medrad, Medtronic, Boston Scientific, more ...

Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies for Pharmaceutical Success in a Global MarketplaceDirect access to this research is not included with your membership level.

In the face of cost and regulatory pressures, clinical programs at pharmaceutical organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities... (ID POP-239)
Companies Profiled: Eisai, Abbott, Daiichi Sankyo, Merck Serono, more ...

Best Practices in the Oversight and Management of Investigator-Initiated Trials in OncologyDirect access to this research is not included with your membership level.

As the number of investigator initiated trial (IIT) submissions continues to rise for Oncology drug candidates, it has become a critical operational ... (ID POP-341)
Companies Profiled: Becton Dickinson, Bayer, Cipla, Daiichi Sankyo, more ...

Innovation in Combo Product Clinical Development – Harnessing Patient Insights from Reported Usability OutcomesDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

As the healthcare industry gravitates toward increased patient centricity in an all-out effort to achieve the best possible health outcomes, it follo... (ID POP-308)
Companies Profiled: Novartis, Windtree Therapeutics, EMD Serono, Merck, more ...

Best Practices in Distributing Medical Info to Investigators and Physicians through Investigator Portals and Other MeansDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Effective Medical Information groups must evaluate and prioritize how they disseminate critical information to a variety of key external stakeholders... (ID POP-329)
Companies Profiled: AbbVie, Allergan, Alnylam Pharmaceuticals, Boehringer Ingelheim, more ...

Managing Market Planning for New Oncology ProductsDirect access to this research is not included with your membership level.

Understand how leading pharmaceutical companies effectively manage market planning for oncology products during Phase II and Phase III... (ID PSM-205)

$628.00

Clinical Trial Excellence: Toolkit for Winning Investigators in a Competitive MarketplaceDirect access to this research is not included with your membership level.

Market competition is mounting to win the time, attention and interest of the most qualified clinical investigators... (ID OP-105)
Companies Profiled: ALTANA Pharmaceuticals, 3M Pharmaceuticals, Amersham Health, Amgen, more ...

KEYTRUDA Case Study: How Merck Used Bold Indications Planning Coupled with Expansive Clinical Trials to Lift a Second-To-Market Product into the Annals of Blockbuster Launch HistoryDirect access to this research is not included with your membership level.

KEYTRUDA’s (pembrolizumab) rise from near obscurity to blockbuster status was anything but certain... (ID PSM-392)
Companies Profiled: Merck, Advaxis, Ascentage Pharma, Astellas, more ...

Best Practices in the Oversight and Management of Investigator Initiated TrialsDirect access to this research is not included with your membership level.

The number of investigator-initiated trial (IIT) submissions in the healthcare industry has increased in recent years, marking them as a critical operational area for most biopharma manufacturers... (ID POP-327)
Companies Profiled: Alcon, Allergan, Arena Pharmaceuticals, Bayer, more ...